Naegis Pharmaceuticals Inc.
$50,000.00 CAD
≈ 8 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2020-2021
- Agreement period
- January 15, 2021 – March 31, 2021
- Reference
- nrc-cnrc:172-2020-2021-Q4-964084
Published purpose
The project will involve conducting proof of concept in vivo efficacy and isolation of an optically pure lead compound to support development of a novel therapeutic as a potential treatment for certain sight-threatening ocular inflammatory disorders.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions